PT  - JOURNAL ARTICLE
AU  - Ebrahim Sahafizadeh
AU  - Samaneh Sartoli
TI  - Estimating the reproduction number of COVID-19 in Iran using epidemic modeling
AID  - 10.1101/2020.03.20.20038422
DP  - 2020 Jan 01
TA  - medRxiv
PG  - 2020.03.20.20038422
4099  - http://medrxiv.org/content/early/2020/03/29/2020.03.20.20038422.short
4100  - http://medrxiv.org/content/early/2020/03/29/2020.03.20.20038422.full
AB  - Background As reported by Iranian governments, the first cases of coronavirus (COVID-19) infections confirmed in Qom, Iran on February 19, 2020 (30 Bahman 1398). The number of identified cases afterward increased rapidly and the novel coronavirus spread to all provinces of the country. This study aimed to fit an epidemic model to the reported cases data to estimate the basic reproduction number (RO) of COVID-19 in Iran.Methods We used data from February 21, 2020, to March 18, 2020, on the number of cases reported by Iranian governments and we employed the SIR (Susceptible-Infectious-Removed) epidemic spreading model to fit the transmission model to the reported cases data by tuning the parameters in order to estimate the basic reproduction number of COVID-19 in Iran.Results The value of reproduction number was estimated 4.86 in the first week and 4.5 in the second and decreasing from 4.29 to 2.1 in the third and fourth weeks.Conclusions The results indicate that the basic reproduction number of COVID-19 is significantly larger than one. Based on the results, it is necessary to implement social distancing and a strict restriction on travelling to control the outbreak especially on Nowruz (Persian New Year).Competing Interest StatementThe authors have declared no competing interest.Funding StatementThe authors received no specific funding for this work.Author DeclarationsAll relevant ethical guidelines have been followed; any necessary IRB and/or ethics committee approvals have been obtained and details of the IRB/oversight body are included in the manuscript.YesAll necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesInformation related to the study is in the manuscript